# 2025-06879: NIH Holds Secret Session on New Drug Contracts

2025-06879, National Center for Advancing Translational Sciences; Notice of Closed Meeting, is a Federal Register notice from Health and Human Services Department, National Institutes of Health published 2025-04-22, effective 2025-05-14 (as of 2026-06-08).

- Canonical: https://policyrisk.com/federal-register/2025-06879
- As of: 2026-06-08
- Plain-text twin of the page above; the HTML and this file carry the same facts.

## Facts
- Document number: 2025-06879
- Title: National Center for Advancing Translational Sciences; Notice of Closed Meeting
- Type: Notice
- Agencies: Health and Human Services Department; National Institutes of Health
- Citation: 90 FR 16877
- Published: 2025-04-22
- Effective: 2025-05-14
- Comments close: not stated
- Significant: no
- Touches household money: no
- Regulation identifier numbers: none
- Last updated: 2026-06-08

## In one line

NIH Holds Secret Session on New Drug Contracts

## Summary

The National Center for Advancing Translational Sciences is holding a private meeting on May 14-15, 2025, to review secret contract proposals about developing new drug products. This meeting affects companies and researchers involved in drug development and keeps sensitive info safe. No public money changes are announced, but the decisions could impact future drug research funding.

## Effects PRIA read

No economic effects identified for this document.

## Related documents

- [2026-22871](https://policyrisk.com/federal-register/2026-22871): Center for Scientific Review; Notice of Closed Meetings, 2026-11-10
- [2026-22550](https://policyrisk.com/federal-register/2026-22550): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22558](https://policyrisk.com/federal-register/2026-22558): Center for Scientific Review; Notice of Closed Meetings, 2026-11-05
- [2026-22339](https://policyrisk.com/federal-register/2026-22339): Prospective Grant of Exclusive Patent License: Catheter-Based Intramyocardial Ablation for Treating Ventricular Arrhythmia in a Human, 2026-11-02
- [2026-22196](https://policyrisk.com/federal-register/2026-22196): National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Meeting, 2026-10-30
- [2026-22111](https://policyrisk.com/federal-register/2026-22111): Eunice Kennedy Shriver National Institute of Child Health & Human Development; Notice of Meeting, 2026-10-29

## Sources
- [2025-06879 on federalregister.gov](https://www.federalregister.gov/documents/2025/04/22/2025-06879/national-center-for-advancing-translational-sciences-notice-of-closed-meeting)
- [2025-06879 as published (PDF)](https://www.govinfo.gov/content/pkg/FR-2025-04-22/pdf/2025-06879.pdf)

## Related
- [Previous: 2025-06878, Prospective Grant of an Exclusive Patent License: Size-Dependent Brain and Lymp…](https://policyrisk.com/federal-register/2025-06878)
- [Next: 2025-06882, Svetlana Burtman, N.P.; Decision and Order](https://policyrisk.com/federal-register/2025-06882)
- [All Federal Register documents](https://policyrisk.com/federal-register)

Source: PRIA, https://policyrisk.com/federal-register/2025-06879 (as of 2026-06-08).
